Quadrant Capital Group’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2
Closed -$3 2530
2025
Q1
$3 Buy
+2
New +$3 ﹤0.01% 2743